Section 46, Assisted Reproductive Technology (Regulation) Act, 2021 [S2A-S14]
As at 7 September 2026. In force from 12 May 2022 by S.O. 252(E) [N12-MJG].
46. Registration of manufacturers.—(1) Every manufacturer shall, within fifteen days from the commencement of this Act or, where such person begins the manufacture of drugs after such commencement, within fifteen days from the date of such beginning, make an application for registration to the Licensing Authority in Form 25, accompanied by a fee of two thousand rupees. (2) The Licensing Authority shall, on being satisfied that the application is in order, register the applicant and issue a certificate of registration in such form as may be prescribed. (3) No manufacturer shall carry on the manufacture of drugs unless registered under this section.
Defined terms in this text (3)
drug: Section 2, Assisted Reproductive Technology (Regulation) Act, 2021 [S2AQNM] (In this Act, unless the context otherwise requires,—): "drug" includes all medicines for internal or external use of human beings or animals and all substances intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder in human beings or animals
drug: 19 more definitions.
Licensing Authority: Section 2, Assisted Reproductive Technology (Regulation) Act, 2021 [S2AQNM] (In this Act, unless the context otherwise requires,—): "Licensing Authority" means the authority appointed under section 4 to grant licences under this Act
Licensing Authority: 21 more definitions.
manufacture: Section 2, Assisted Reproductive Technology (Regulation) Act, 2021 [S2AQNM] (In this Act, unless the context otherwise requires,—): "manufacture" in relation to any drug, includes any process or part of a process for making, altering, ornamenting, finishing, packing, labelling, breaking up or otherwise treating or adopting any drug with a view to its sale or distribution
manufacture: 36 more definitions.
Made under this section, or naming it (0)
none
Cited by (0)
none
Not held (0)
none
Duties published under this section (0)
none